决定继续或停止服用抗精神病药物的因素:对12名从第一次精神病中恢复过来的个体进行的探索性定性研究
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
在PubMed上查看摘要
概括
此摘要是机器生成的。从第一次精神病发作 (FEP) 康复的患者通常会决定停止服用抗精神病药物,因为他们受到个人康复目标和副作用的影响. 需要积极的临床讨论来支持共同的决策.
科学领域
- 精神病学
- 临床心理学
- 神经科学
背景情况
- 在第一次精神病发作 (FEP) 中,抗精神病治疗的延续/停止是复杂的.
- 停药后可能会复发,但长期的副作用 (代谢,超) 是令人担忧的.
- 指导方针建议1-5年的治疗和共享决策 (SDM).
研究的目的
- 探索FEP中抗精神病治疗的决策过程.
- 确定患者感知到影响停药或继续治疗的因素.
- 了解患者对缓解后治疗管理的看法.
主要方法
- 描述性的定性研究.
- 在加拿大北克省,
- 在线半结构面试和主题分析.
主要成果
- 受疾病/治疗观念,耻辱和社会关系影响的决策.
- 与福祉和社会贡献相关的决策的动机.
- 大多数参与者认为临床医生没有启动停药讨论.
结论
- 患者的康复动机显著影响抗精神病治疗决策.
- 需要主动,个性化的临床医生与患者的讨论.
- 为支持SDM,建议为FEP群体开发量身定制的决策辅助工具.
相关概念视频
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...